TrialAmerican journal of respiratory and critical care medicine2023

A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19.

Michael E Bowdish et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.